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Abstract
Motivation: Identifying the genetic basis of the brain structure, function and disorder by using the
imaging quantitative traits (QTs) as endophenotypes is an important task in brain science. Brain
QTs often change over time while the disorder progresses and thus understanding how the genetic
factors play roles on the progressive brain QT changes is of great importance and meaning. Most
existing imaging genetics methods only analyze the baseline neuroimaging data, and thus those
longitudinal imaging data across multiple time points containing important disease progression in-
formation are omitted.
Results: We propose a novel temporal imaging genetic model which performs the multi-task
sparse canonical correlation analysis (T-MTSCCA). Our model uses longitudinal neuroimaging
data to uncover that how single nucleotide polymorphisms (SNPs) play roles on affecting brain
QTs over the time. Incorporating the relationship of the longitudinal imaging data and that within
SNPs, T-MTSCCA could identify a trajectory of progressive imaging genetic patterns over the time.
We propose an efficient algorithm to solve the problem and show its convergence. We evaluate
T-MTSCCA on 408 subjects from the Alzheimer’s Disease Neuroimaging Initiative database with
longitudinal magnetic resonance imaging data and genetic data available. The experimental results
show that T-MTSCCA performs either better than or equally to the state-of-the-art methods. In
particular, T-MTSCCA could identify higher canonical correlation coefficients and capture clearer
canonical weight patterns. This suggests that T-MTSCCA identifies time-consistent and time-
dependent SNPs and imaging QTs, which further help understand the genetic basis of the brain QT
changes over the time during the disease progression.
Availability and implementation: The software and simulation data are publicly available at https://
github.com/dulei323/TMTSCCA.
Contact: dulei@nwpu.edu.cn or li.shen@pennmedicine.upenn.edu
Supplementary information: Supplementary data are available at Bioinformatics online.
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1 Introduction
Brain imaging genetics studies the relationship between the quantita-
tive traits (QTs) extracted from neuroimaging data and genotypic
data such as single nucleotide polymorphisms (SNPs). This research
methodology is expected to uncover the genetic basis of brain struc-
ture and function, thereby further offers new opportunities to inter-
pret the relationships between genetic variations and brain disorders
(Potkin et al., 2009; Saykin et al., 2015; Shen et al., 2010).
During the last decade, many efforts have been made to explore
computational methods to identify the correlation between QTs and
genetic factors (Du et al., 2016, 2018; Hao et al., 2017; Shen et al.,
2010; Vounou et al., 2010, 2012; Wang et al., 2012b; Witten and
Tibshirani, 2009; Yan et al., 2014). The early imaging genetic stud-
ies (Shen et al., 2010; Vounou et al., 2010) used pairwise univariate
analysis to identify single-SNP-single-QT associations. To improve
the identification power, the multivariate sparse regression methods
were introduced later (Vounou et al., 2012; Wan et al., 2011; Wang
et al., 2012b). They either regressed a set of SNPs for a few candi-
date QTs, or regressed a set of QTs for a few candidate SNPs, and
the relationship among predictors is usually taken into consideration
via the regularization.
Recently, sparse canonical correlation analysis (SCCA) becomes
popular in imaging genetics since it can identify bi-multivariate asso-
ciations between multiple SNPs and multiple imaging QTs without
pre-selecting candidate biomarkers (Du et al., 2016; Witten and
Tibshirani, 2009; Yan et al., 2014). Most existing SCCA methods
only employ neuroimaging data of one time point, e.g. the baseline,
to study their correlation with SNPs. Neuroimaging techniques
show improved power in investigating the characteristics of neuro-
degenerative progression in the spectrum from healthy controls
(HCs) to patients with Alzheimer’s disease (AD) (Cheng et al.,
2019). Thus, the brain structure and function along with the disease
diagnosis change over time other than remain stationary. For ex-
ample, a HC subject might progress to mild cognitive impairment
(MCI) patient, and further to AD several years later; while another
HC subject could remain healthy during these years. Therefore,
understanding how the genetic factors modulate the trajectory of
disease progression is particularly important and interesting.
The aforementioned methods might be insufficient to discover
deep-seated imaging genetic relationship due to the ignorance of rich
temporal information carried by the imaging data across multiple time
points. To date, there are a few methods studying imaging genetics
using the longitudinal phenotypic data. A common issue is that a pre-
selection of candidate risk biomarkers is required before conducting
the actual imaging genetic analysis. For example, Vounou et al. (2010)
proposed a two-step method which first selected a small set of disease-
related imaging voxels which can distinguish AD subjects from HC
ones. Then a sparse reduced-rank regression was applied to identify
those disease relevant SNPs by using the pre-selected voxels as
responses and SNP as predictors (Vounou et al., 2012). Given the
complexity of the human brain (Mai et al., 1997), only including a
small proportion might be insufficient since this may lose important
information carried by cerebral components which are not included
(Shen et al., 2010). Wang et al. (2012a) proposed a sparse regression
model which uses a small set of pre-selected SNPs as responses and the
brain-wide imaging phenotypes as predictors. Instead of identifying
disease relevant SNPs (Vounou et al., 2010), it identifies disease rele-
vant brain imaging phenotypes with common influence on all candi-
date SNPs (Wang et al., 2012a). Recently, Hao et al. (2017) proposed
a temporally constrained group SCCA (TGSCCA) which simplified
the multi-set/multi-view SCCA (mSCCA) model (Witten and
Tibshirani, 2009) by dropping the pairwise association between longi-
tudinal imaging phenotypes. Both TGSCCA and mSCCA require that
one set of variables (SNPs) being associated with several sets of varia-
bles (longitudinal imaging QTs across multiple time points) simultan-
eously, which might be too strict to make full use of the
complementary information embedded in different period of imaging
data. Moreover, TGSCCA identified time-consistent markers for
imaging QTs, which only revealed those relevant markers being shared
by all time points. As a result, it could not uncover the heterogeneous
progressive patterns of human brain. Neuroimaging studies have
shown that the human brain cerebral decline, e.g. the atrophy in AD,
presents regional differences in the atrophy rates (Fox and Schott,
2004; Harper et al., 2017). This implies that, in many cases, the com-
mon progressive pattern is shared by multiple time points, but not all
(Lee et al., 2010; Wang et al., 2011). This regional variations may
trace back to the involvement of different SNPs at different time
points. Therefore, developing longitudinal imaging genetics methods,
with the ability of identifying a trajectory of progressive and time-
dependent imaging genetic patterns, is of great importance and mean-
ing. This could further help uncover the diverse genetic factors’ roles
in affecting brain changes over the disease progression.
In this article, using the longitudinal brain imaging QTs across
multiple time points, we propose a novel Temporal Multi-Task
SCCA (T-MTSCCA) framework which learns bi-multivariate associ-
ations between intermediate phenotypes and genotypes simultan-
eously. In this new model, each SNP or QT is denoted as a feature,
and an SCCA task is conducted between each longitudinal imaging
modality and SNPs. Distinct from mSCCA and TGSCCA who learn
only one canonical weight vector for SNPs, our T-MTSCCA learns a
canonical weight matrix for SNPs, where each column corresponds
to one canonical weight of one SCCA task. This means that our
method can make full use of the complementary information carried
by imaging QTs at different time points. The inherent linkage dis-
equilibrium (LD) (Pritchard and Przeworski, 2001) structure is
taken into consideration by the group ‘2;1-norm (G2;1-norm) (Wang
et al., 2012b) to make the model practical. The ‘2;1-norm is used to
jointly select an individual feature for SNPs and phenotypic QTs.
The longitudinal imaging QTs naturally present a temporal pattern
across multiple time points, we use a fuse pairwise group lasso to ac-
commodate this temporal relationship. In addition, the ‘1-norm for
both SNPs and imaging QTs assures a time-dependent feature selec-
tion, indicating its capability in finding markers which are only ef-
fective at a specific time point. We derive an efficient algorithm and
show its convergence to a local optimum.
In the experiments, to evaluate the performance of T-MTSCCA,
we used synthetic datasets with different characters and a real neu-
roimaging genetic dataset from the Alzheimer’s disease neuroimag-
ing initiative (ADNI) (Mueller et al., 2005) cohort. The real data
included longitudinal structural magnetic resonance imaging (MRI)
measurements over a two year period and 1085 SNPs near the
APOE gene. Compared with two state-of-the-art methods, on both
synthetic and real datasets, our method yielded improved canonical
correlation coefficients, and clear canonical weight profiles showing
its capability in identifying relevant biomarkers. Moreover, T-
MTSCCA also identified time-dependent and progressive imaging
and genetic markers, demonstrating it is a potential alternative
method in longitudinal brain imaging genetics.
2 Materials and methods
Throughout this article, we denote scalars as italic letters, vectors as
boldface lowercase letters and matrices as boldface uppercase
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letters. The i-th row and j-th column of matrix X ¼ ðxi;jÞ are
denoted as xi and xj, respectively. The i-th matrix of a set of matri-
ces is denotes as Xi. The Euclidean norm of x is denoted as kxk2 and
the Frobenius norm of X is defined as kXkF ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP
i
P
j x
2
i;j
q
.
2.1 The sparse canonical correlation analysis
Canonical correlation analysis (CCA) combined with sparse learning
techniques is widely used in imaging genetics. Suppose we have T
matrices, i.e. Xiði 2 ½1; . . . ;TÞ and T canonical weights wi, the
SCCA can be formally defined as:
min
w1 ;...;wT
X
t< k
w>t X>t Xkwk þ ktXðwtÞ (1)
s:t: kXtwtk22 ¼ 1; 8t:
XðwtÞ is the sparsity-inducing term to select those features of
interest and kt is the parameter to control the strength of sparsity. So
far, SCCA studies have involved the Lasso (‘1-norm) (Parkhomenko
et al., 2009; Witten and Tibshirani, 2009), group Lasso (Chen and
Liu, 2012; Du et al., 2017) and graph Laplacian regularization
(Chen and Bushman, 2013; Du et al., 2016; Yan et al., 2014), to
name a few. For the sake of description, we name an SCCA method
based on the number of matrices involved. For example, we call it
two-view or two-set SCCA (SCCA for short) when t¼2, and most
existing studies are in this category. The multi-view or multi-set
SCCA (mSCCA) studies the associations among three or more matri-
ces (t  3).
The temporally constrained group SCCA (TGSCCA) (Hao et al.,
2017) is introduced by relating the SNP data to the imaging data at
each time point separately while enforcing a shared canonical load-
ing on the genetic side, i.e.
min
u;v1 ;...;vT
XT
t¼1
u>X>Ytvt þ kuXðuÞ þ kvXðVÞ (2)
s:t: kXuk22 ¼ 1; kYtvtk22 ¼ 1; 8t:
X 2 Rnp here represents the genotype SNPs data with n subjects
and p SNPs, Yt 2 Rnqðt ¼ 1; . . . ;TÞ represents the longitudinal
phenotype data with q imaging QTs, where T is the number of time
points and V ¼ ½v1 v2    vT .
2.2 The T-MTSCCA
In this subsection, we aim to investigate the association between
genotypes and longitudinal imaging phenotypes. In view that imag-
ing phenotypes show regional variations over time owing to the im-
pact of genotypes, the computational model should account for the
regional variations. Inspired by the success of multi-task regression
in imaging genetics studies (Wang et al., 2012a, b), we propose a
novel temporal multi-task SCCA (T-MTSCCA) method for longitu-
dinal imaging genetics as follows:
min
ut ;vt
XT
t¼1
u>t X>Ytvt þXðUÞ þ XðVÞ (3)
s:t: kXutk22 ¼ 1; kYtvtk22 ¼ 1; 8t;
where U ¼ ½u1 u2    uT ; V ¼ ½v1 v2    vT  and T is the number
of time points (SCCA tasks). XðUÞ and XðVÞ are the regularization
terms for selection of time-dependent and time-consistent genotypic
and imaging phenotypic markers.
T-MTSCCA has three advantages over previous models mSCCA
and TGSCCA. First, T-MTSCCA is a multi-task bi-multivariate
method which jointly learns related SCCA tasks. The neurodegener-
ative disorders, e.g. AD, usually deteriorate gradually, implying the
brain structure and function, might show little difference between
two consecutive visits. This indicates that the longitudinal imaging
QTs remain stable during this period, which further reveals that
these SCCA tasks regarding associations between genotypes and lon-
gitudinal imaging phenotypes are correlated longitudinally.
According to the multi-task learning theory (Argyriou et al., 2006),
T-MTSCCA is expected to yield enhanced performance owing to
these longitudinally correlated SCCA tasks. Second, T-MTSCCA
learns a weight matrix U with T vectors corresponding to T SCCA
tasks. That is, an SCCA task will promote correlated tasks instead
of enforcing them to be the same, which is meaningful when these
tasks (associations between SNPs and longitudinal imaging pheno-
types at different time points) are not perfectly related (Lee et al.,
2010). This strategy seeks common ground while reserving differen-
ces and offers a unique opportunity to identify both time-consistent
and time-dependent markers simultaneously. Third, the blended
regularization XðUÞ subsumes G2;1-norm, ‘2;1-norm and ‘1-norm,
and thus assures diverse sparsity including time-dependent, time-
consistent and smoothness crossing multiple time points but not all.
XðVÞ is also a blended regularization performing diverse feature se-
lection for heterogeneous progressive patterns of imaging QTs.
Therefore, T-MTSCCA is promising in discovering complex region-
al variations existing in the progression of neurodegenerative disor-
ders (Fox and Schott, 2004), and further identifying the deep-seated
QT loci being responsible for the disorders.
2.2.1 Regularization for genotypes via group-sparsity and individ-
ual-sparsity
It is well known that the genetic markers, i.e. SNPs, affect the brain
structure and function both conjointly at group level and individual-
ly. SNPs could exhibit different temporal patterns longitudinally,
being supported by the truth that the human brain cerebral decline
exhibits regional variations longitudinally (Fox and Schott, 2004).
Therefore, in order to take into consideration these complex tem-
poral patterns, XðUÞ is defined as:
XðUÞ ¼ ku1kUkG2;1 þ ku2kUk2;1 þ ku3
Xp
i¼1
kuik1; (4)
where ku1; ku2 and ku3 are non-negative tuning parameters.
Specifically, the G2;1-norm is formulated as follows:
kUkG2;1 ¼
XK
k¼1
kUkkF ¼
XK
k¼1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
X
i2gk
XT
t¼1
ðuitÞ2
vuut : (5)
Uk is the k-th submatrix of U whose rows is indexed by gk. G ¼
fgkgKk¼1 denotes K groups in accordance with the LD structure. This
norm assures group sparsity since it penalizes SNPs in the same
group (e.g. LD) jointly, meaning they will be selected or unselected
simultaneously (Wang et al., 2012b). The penalization is practical
owing to packaging SNPs in the same LD block together, which
makes the model consistent with the genotype mechanism.
The ‘2;1-norm is defined as:
kUk2;1 ¼
Xp
i¼1
kuik2 ¼
Xp
i¼1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
XT
t¼1
ðuitÞ2
vuut : (6)
This regularization emphasizes on a single variable across mul-
tiple tasks, and could help identify a single SNP that plays a role in
the brain development or disease progression via affecting the
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longitudinal imaging phenotypes. Finally, the temporal pattern
implies that a SNP could not always play a role during the disease
progression. Therefore, we use the ‘1-norm for each u
i to induce
sparsity across all time points for each individual SNP, i.e.
kuik1 ¼
XT
t¼1
juitj: (7)
This penalty is focused on selecting the relevant features at a spe-
cific time point. It is worth noting that, combining the three terms
together, they can not only identify active SNPs shared by all time
points, but also identify SNPs being only relevant at a specific time
point.
2.2.2 Regularization for longitudinal imaging phenotypes via time-
consistent and time-dependent sparsity
The regularization aiming for sparsity with respect to imaging QTs
is also desirable, being motivated by the fact that different imaging
QTs play different roles during the disease progression. According
to Equation (3), there is one canonical weight vector for imaging
QTs at a specific time point. Then across multiple times points, an
imaging QT describes the trajectory of the disease progression at
this specific brain area. Based on the analysis earlier, regional varia-
tions, i.e. one brain region may remain stable while another may
change significantly, should be taken into consideration.
On this account, we introduce a novel time-consistent and time-
dependent constraint which is defined as follows:
XðVÞ ¼ kv1kVkFP2;1 þ kv2kVk2;1 þ kv3
Xq
j¼1
kvjk1; (8)
where kv1; kv2 and kv3 are non-negative tuning parameters.
The fused pairwise ‘2;1-norm (FP2;1-norm) (Du et al., 2017) is
defined as:
kVkFP2;1 ¼
Xq
j¼1
XT1
t¼1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðvjtÞ2 þ ðvjtþ1Þ2
q
: (9)
This norm first imposes the ‘2-norm for two adjacent time points
of one QT, then uses the ‘1-norm for all QTs spanning the whole
brain. As a result, the intermediate temporally stable pattern of one
QT is considered as well as the sparsity among all QTs. Moreover,
FP2;1-norm is convex and thus could be easily optimized compared
to the non-convex fused Lasso of TGSCCA (Hao et al., 2017). The
‘2;1-norm:
kVk2;1 ¼
Xq
j¼1
kvjk2 ¼
Xq
j¼1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
XT
t¼1
ðvjtÞ2
vuut ; (10)
is used to assure the cross-task relationship for each imaging QT.
Thus it could select or discard those imaging QTs remaining stable
across all time points. Finally, as stated, the brain areas exhibit dis-
tinct atrophy patterns (Fox and Schott, 2004). Therefore, identifying
time-dependent imaging QTs is also very important to understand
the disease pathology. We use the ‘1-norm penalty, i.e.
kvjk1 ¼
XT
t¼1
jvjtj; (11)
for each vt to assure the individual-sparsity at a specific time point.
Obviously, either the FP2;1-norm, ‘2;1-norm or ‘1-norm alone is
insufficient due to the regional variations of both healthy and patho-
logical brains. Therefore, we use all of them to regularize the
longitudinal imaging QTs to account for both time-consistent and
time-dependent feature selection. This make T-MTSCCA a very
practical model, and thus suitable for longitudinal brain imaging
genetics.
2.3 The optimization algorithm and its convergence
Writing the regularizers for genotypes and imaging phenotypes ex-
plicitly, the T-MTSCCA becomes:
min
ut ;vt
XT
t¼1
 u>t X>Ytvt þ ku1kUkG2;1 þ ku2kUk2;1
þku3
Xp
i¼1
kuik1 þ kv1kVkFP2;1 þ kv2kVk2;1 þ kv3
Xq
j¼1
kvjk1
s:t: kXutk22 ¼ 1; kYtvtk22 ¼ 1; 8t:
(12)
Since 8t; kXutk22 ¼ 1 and kYtvtk22 ¼ 1, Equation (12) is equiva-
lent to:
min
ut ;vt
XT
t¼1
kXut  Ytvtk22 þ ku1kUkG2;1 þ ku2kUk2;1
þku3
Xp
i¼1
kuik1 þ kv1kVkFP2;1 þ kv2kVk2;1 þ kv3
Xq
j¼1
kvjk1
s:t: kXutk22 ¼ 1; kYtvtk22 ¼ 1; 8t:
(13)
It is hard to solve Equation (13) above due to its non-convexity
in the quadratic term and non-smooth in regularization terms. But
the objective is biconvex in U and V even if it is still non-smooth. In
particular, this objective is convex in U with all vt’s fixed; and it is
convex in vt with U and the rest of vt0 ðt0 6¼ tÞ fixed. Therefore, the
solution can be easily attained via first using smoothing approxima-
tions of non-smooth terms, and then applying the efficient smooth
optimization such as the alternative search method (Gorski et al.,
2007).
2.3.1 Updating U
When V is fixed, the Lagrangian of Equation (13) regarding U
writes:
min
U
XT
t¼1
kXut  Ytvtk22 þ ku1kUkG2;1 þ ku2kUk2;1 þ ku3
Xp
i¼1
kuik1
þcu
XT
t¼1
kXutk22;
(14)
with those constants vanish. Now this equation transforms to a
multi-task regression problem.
We take its derivative with respect to each ut and set it to
zero, i.e.
X>Ytvt þ ku1 ~D1ut þ ku2 D1ut þ ku3D1tut þ ð1 þ cuÞX>Xut ¼ 0:
(15)
~D1 is a block diagonal matrix with the k-th diagonal block as
1
2kUkkF
Ik (Ik is an identity matrix with size being equal to the k-th
submatrix Uk, and 1  k  K), D1 is also a diagonal matrix whose
i-th diagonal element is 1
2kuik2 1  i  pÞð and D1t is a diagonal ma-
trix with the i-th diagonal element being 1
2juit j.
This equation indicates that every ut can be solved in closed
form. Simple mathematical derivation yields the updating rule for
each ut, i.e.
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ut ¼ ðku1 ~D1 þ ku2 D1 þ ku3D1t þ ð1 þ cuÞX>XÞ1X>Ytvt: (16)
Since ~D1; D1 and D1t (t ¼ 1; 2; . . . ;T) are latent variables which
depend on U, we can solve Equation (16) using the efficient iterative
algorithm (Wang et al., 2011, 2012b).
2.3.2 Updating V
Now with U being fixed, the objective with respect to vt writes:
min
vt
kXut  Ytvtk22 þ kv1kVkFP2;1 þ kv2kVk2;1 þ kv3kvtk1 þ cvkYtvtk22:
(17)
Taking the derivative with respect to vt and setting it to zero, we
have,
Y>t Xut þ kv1 ~D2tvt þ kv2 D2vt þ kv3D2tvt þ ð1 þ cvÞY>t Ytvt ¼ 0:
(18)
Then, we arrive at:
vt ¼ ðkv1 ~D2t þ kv2 D2 þ kv3D2t þ ð1 þ cvÞY>t YtÞ1Y>t Xut; (19)
where D2; ~D2t and D2t (t ¼ 1; 2; . . . ;T) are all diagonal matrices. In
particular, the j-th diagonal element of ~D2t is
1
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðvj
t1Þ2þðv
j
tÞ2
p þ
1
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðvjtÞ2þðvjtþ1Þ2
p (1  j  q; 1  t  T) (The j-th diagonal elements
of ~D2t is
1
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðvjtÞ2þðvjtþ1Þ2
p when t ¼ 1, and 1
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðvj
t1Þ2þðv
j
tÞ2
p when t ¼ T.).
The j-th diagonal element of D2 is
1
2kvjk2, and that of D2t is
1
2jvjt j
. This
closed form shows that each vt can be obtained via the alternative it-
eration algorithm too.
Now that U and V are solved, respectively, we summarize the
optimization procedure in Algorithm 1, which guarantees to con-
verge to a local optimum. In the iteration, Steps 1, 3 and 5 are com-
putationally trivial. Steps 4 and 6 solve a system of linear equations,
both of which are well studied in literature and can be solved
efficiently.
2.3.3 Convergence analysis
The following theorem holds for Algorithm 1.
THEOREM 1. The objective decreases in each iteration of Algorithm 1.
PROOF. Denote the current estimate of U and V, respectively, as U and V
(with a slight abuse of notation, for notational convenience), and their
refined estimates using the updating rules in Equations (16) and (19) as
U^ and V^. Denote the objective function value of problem (13) as
f ðU;VÞ.
According to the update rule in Equation (16), we have,
XT
t¼1
kXu^t  Ytvtk22 þ ku1TrðU^
> ~D1U^Þ þ ku2TrðU^> D1U^Þ þ ku3
XT
t¼1
u^>t D1tu^t
þcuTrðU^
>
X>XU^Þ 
XT
t¼1
kXut  Ytvtk22 þ ku1TrðU> ~D1UÞ
þku2TrðU> D1UÞ þ ku3
XT
t¼1
u>t D1tut þ cuTrðU>X>XUÞ
)
XT
t¼1
kXu^t  Ytvtk22 þ ku1
XK
k¼1
kU^kk2F
2kUkkF
þ ku2
Xp
i¼1
ku^ ik22
2kuik2
þku3
Xp
i¼1
XT
t¼1
ju^ itj2
2juitj
þ cukXU^k2F 
XT
t¼1
kXut  Ytvtk22 þ ku1
XK
k¼1
kUkk2F
2kUkkF
þku2
Xp
i¼1
kuik22
2kuik2
þ ku3
Xp
i¼1
XT
t¼1
juitj2
2juitj
þ cukXUk2F:
Applying kU^kkF  kU^
kk2F
2kUkkF
 kUkkF  kU
kk2F
2kUkkF
, ku^ ik2  ku^
ik22
2kuik2  ku
ik2
kuik22
2kuik2 and ju
^ i
tj  ju
^
i
t j2
2juit j  ju
i
t j  ju
i
t j2
2juit j [Lemma 1 in (Wang et al., 2012b)] to
Equation (2.3.3) with respect to each group and individual features, re-
spectively, we arrive at:
XT
t¼1
kXu^t  Ytvtk22 þ ku1
XK
k¼1
kU^kkF þ ku2
Xp
i¼1
ku^ik2 þ ku3
Xp
i¼1
XT
t¼1
ju^ itj
þcukXU^k2F 
XT
t¼1
kXut  Ytvtk22 þ ku1
XK
k¼1
kUkkF
þku2
Xp
i¼1
kuik2 þ ku3
Xp
i¼1
XT
t¼1
juitj þ cukXUk2F:
Writing in matrix form, we obtain:
XT
t¼1
kXu^t  Ytvtk22 þ ku1kU^kG2;1 þ ku2kU^k2;1 þ ku3
Xp
i¼1
ku^ ik1
þcu
XT
t¼1
kXu^tk22 
XT
t¼1
kXut  Ytvtk22 þ ku1kUkG2;1 þ ku2kUk2;1
þku3
Xp
i¼1
kuik1 þ cu
XT
t¼1
kXutk22:
This reveals that, in each iteration of Equation (16), the objective
decreases, namely, f ðU^;VÞ  f ðU;VÞ.
Similarly, we can prove the convergence of updating vt ’s one by one.
Combined, in equations with respect to each vt yields:
XT
t¼1
kXu^t  Yt v^tk22 þ kv1kV^kFP2;1 þ kv2kV^k2;1 þ kv3
Xq
j¼1
kv^ jk1
þcv
XT
t¼1
kYt v^tk22 
XT
t¼1
kXu^t Ytvtk22 þ kv1kVkFP2;1 þ kv2kVk2;1
þkv3
Xq
j¼1
kvjk1 þ cv
XT
t¼1
kYtvtk22;
from which it follows that f ðU^; V^Þ  f ðU^;VÞ.
Combining two conclusions above yields f ðU^; V^Þ  f ðU^;VÞ 
f ðU;VÞ, which completes the proof. h
Algorithm 1 The T-MTSCCA algorithm
Require:
The genotype data matrix X 2 Rnp, longitudinal imaging
phenotype data matrices of T time points Yt 2 Rnq;
t 2 ½1;T, the pre-tuned ku1; ku2; ku3, cu, kv1; kv2; kv3 and
cv.
Ensure:
Canonical weights U and V.
1: Initialize U 2 RpT ; V 2 RqT ;
2: while not convergence do
3: Update ~D1; D1 and D1t (t ¼ 1; 2; . . . ;T);
4: Solve U according to Equation (16), and scale ut as that
kXutk22 ¼ 1;
5: Update D2; ~D2t and D2t (t ¼ 1; 2; . . . ;T);
6: Solve vt alternatively according to Equation (19), and
scale vt so that kYtvtk22 ¼ 1;
7: end while
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Since both objectives of problems Equations (14) and (17) are lower
bounded by zero and the T-MTSCCA problem is biconvex, the overall
iteration algorithm will converge to a local optimum. In our experi-
ments, we terminate Algorithm 1 when maxi;tju^ it  ujtj   and
maxj;tjv^ it  vjtj   satisfy, where  is the pre-set error bound. We use  ¼
105 in this article empirically based on experiments.
3 Experimental results and discussions
3.1 Experimental setup
In the experiments, we compare T-MTSCCA with two close coun-
terparts including the mSCCA (multi-view SCCA) and TGSCCA
(temporally constrained group SCCA) using both synthetic data and
real neuroimaging genetic data. The mSCCA computes pairwise cor-
relation coefficients between the SNPs data and the imaging QTs
data including that between every two modalities of imaging QTs at
different time points (Witten and Tibshirani, 2009). TGSCCA is
similar to mSCCA by dropping the pairwise correlation terms be-
tween those imaging QTs data at different time points (Hao et al.,
2017).
We use the nested 10-fold cross-validation method to find the
optimal parameters. These parameters generating the highest cross-
task mean testing correlation coefficient will be chosen as the opti-
mal parameters, i.e. CVðk; b; cÞ ¼ 110
P10
j¼1
PT
t¼1 Corrð Xjuj;t; Y j;tvj;tÞ,
where Xj and Y j;t are the j-th fold which are the complementary sets
used for testing, and uj;t and vj;t are the canonical weights estimated
from the training set. To further reduce the time effort, we fix cu ¼
1 and cv ¼ 1 since they result in two scaling steps in Algorithm 1,
and thus only affect the magnitude of U and V (Chen and Liu,
2012). This indicates that the relative relationship among each vari-
ables remain the same. Finally, we tune these parameters from can-
didate range 10i (i ¼ 5;4; . . . ;0; . . . ; 4;5), within which the
results are from less-sparsity to over-sparsity. Once determined, we
use the tuned parameters to obtain the final training and testing
results. In each experiment, all methods are stopped if
maxijuðtþ1Þu
ðtÞ
i
i j   and maxjjv
ðtþ1ÞvðtÞ
j
j j  , with  being the toler-
able error.  is set to 105 empirically in this article.
3.2 Results on simulation data
In this simulation study, to evaluate the T-MTSCCA method, we
used four synthetic datasets with distinct properties which could
thoroughly access the performance. First, we generated one sparse
vector u 2 Rp1 and four successive sparse vectors vt 2 Rq1. In
particular, several non-zero variables are shared by all vt’s while
some ones are time-dependent. Then, using a latent vector z 2 Rn1,
we create X by xi  Nðziu; e  IppÞ, and each Yt by
yt;i  Nðzivt; e  IqqÞ. Being embedded with different strengths of
noise, the first three datasets share the same ground truth, i.e.
n¼80, p¼100 and q¼120, on which could show one method’s
performance under different noises. The fourth dataset simulated a
large and complex imaging genetic problem (n¼500, p¼2000 and
q¼600). The details of the ground truths are presented in Figure 2
(top row).
We presented the testing canonical correlation coefficients
(CCCs) in Figure 1 (training CCCs are omitted due to the space limi-
tation). The CCCs, i.e. CCC_T1, CCC_T2, CCC_T3, CCC_T4, of
each method were calculated between X and Yt at every time point.
In this figure, all methods obtained low testing CCCs, indicating
they were over-fitted when the true CCC was quite low. As
expected, their performances improve as the CCC increased. T-
MTSCCA and TGSCCA obtained better CCCs than mSCCA on
data 2 and data 3 attributing to the temporal constraints. On data 4
with thousands of variables, T-MTSCCA and TGSCCA also hold
better CCCs than mSCCA, which demonstrates they were suitable
for longitudinal imaging genetics.
In addition, the ability of feature selection, i.e. the selected SNPs
and imaging QTs at intermediate time points, is also important. To
make the results stable, we averaged the canonical weights across
10-folds and shown them in Figure 2. The actual U and V were
shown on the top row followed by those estimated by mSCCA,
TGSCCA and T-MTSCCA. Within each method’s panel, the canon-
ical weights associated with all time points were stacked vertically.
It is clear that T-MTSCCA identified a clear and clean pattern in
terms of both U and V, whose non-zero variables were consistent to
the ground truth. TGSCCA also obtained acceptable results due to
its temporal constraint for the intermediate imaging QTs. It is worth
mentioning that T-MTSCCA also identified time-dependent non-
zero variables for U and V thanks to its novel time-dependent penal-
ties. This is very interesting since, combined with the time-consistent
penalty, our T-MTSCCA can not only identify those active variables
at a specific time point, but also identify those active variables
shared by all time points. To summarize, the results on this four dis-
tinct synthetic datasets demonstrate that T-MTSCCA could be a
competitive alternative method for longitudinal bi-multivariate asso-
ciation’s identification.
3.3 Results on real neuroimaging genetic data
The real genotyping and brain imaging data used in this article were
obtained from the ADNI database (adni.loni.usc.edu). The primary
goal of ADNI has been to test whether serial MRI, positron emission
tomography (PET), other biological markers and clinical and
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Fig. 1. Comparison of the mean canonical correlation coefficients (CCCs)
obtained from 10-fold cross-validation trials. The CCCs at all time points are
illustrated, where CCC_T1 is calculated between the SNP data and the imag-
ing data at T1, and so forth.
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Fig. 2. Heat maps of canonical weights on synthetic data. Rows 1–4: Ground
truth, mSCCA, TGSCCA and T-MTSCCA, respectively. In each row, U is on the
left panel and V is on the right. Within each panel, there are four canonical
weights associating with four time points. For our method, there are four ca-
nonical weights corresponding to four time points, i.e. T1, T2, T3, T4, for both
U and V. For mSCCA and TGSCCA, the weight matrix U is stacked by the
same canonical weight vector u.
Identifying progressive imaging genetic patterns via MTSCCA i479
neuropsychological assessment can be combined to measure the pro-
gression of MCI and early AD. For up-to-date information, see
www.adni-info.org.
The longitudinal neuroimaging data were from 408 non-
Hispanic Caucasian participants, including 125 healthy controls
(HC), 192 MCI and 91 AD subjects at the baseline screening.
Table 1 shown the demographic information. We used MRI T1-
weighted imaging including baseline (BL), Month 06 (M6), Month
12 (M12) and Month 24 (M24) in this work. These preprocessed
imaging data, i.e. the voxel-based morphometry (VBM), were
aligned to each participant’s same visit scan. Then the normalized
gray matter density maps were created from MRI data in the stand-
ard Montreal Neurological Institute (MNI) space as 2  2  2 mm3
voxels via the SPM software (Ashburner and Friston, 2000). Based
on the MarsBaR AAL atlas (Tzourio-Mazoyer et al., 2002), we fur-
ther extracted 116 ROI level measurements of mean gray matter
densities. Finally, we removed the cerebellum area and obtained 90
imaging measures, and finally used them as phenotypes of four time
points in the experiments. Before the experiment, the imaging meas-
ures were adjusted by removing the effects of the baseline age, gen-
der, education and handedness.
The genotyping data of the same 408 subjects were downloaded
from the ADNI website too. The SNPs were generated by the
Human 610-Quad or OmniExpress Array (Illumina, Inc., San
Diego, CA, USA), and preprocessed according to the standard qual-
ity control (QC) and imputation steps. We included 1085 SNPs
from the neighbor of the APOE gene based on the ANNOVAR an-
notation (see the Supplementary file). We aim to study associations
between SNPs and longitudinal brain imaging measures, and iden-
tify those time-consistent and time-dependent markers in this ADNI
dataset.
3.3.1 Improved bi-multivariate association
We applied three methods to this real neuroimaging genetic data.
mSCCA and TGSCCA yielded one canonical weight u and four ca-
nonical weights vt associating with four longitudinal time points. By
calculating association between SNPs and each imaging QTs of dif-
ferent time points, we obtained four CCCs for them. Our method
naturally generated four pairs of canonical weights, and thus there
were four CCCs with respect to four time points. We denoted these
four CCCs as CCC_BL, CCC_M6, CCC_M12 and CCC_M24 for
the sake of description, and presented them in Figure 3 separately.
In this figure, the testing CCCs was shown with those training ones
omitted due to the space limitation. As expected, owing to the util-
ization of temporal regularization, both TGSCCA and T-MTSCCA
obtained better CCCs than mSCCA. This shows their effectiveness
in longitudinal bi-multivariate association studies.
3.3.2 Identification of time-consistent and time-dependent SNPs
Besides the CCC which showing the strength of the association, the
identification of longitudinally active SNPs and imaging QTs is of
great importance. These time-dependent patterns help uncover the
basis of the diverse progression stages of diseases. We illustrated the
weight matrix U, whose absolute values show the importance of
SNPs, of each method in Figure 4. In this figure, each subfigure
denotes a method, within which each row corresponds to one ca-
nonical weight at one time point. mSCCA and TGSCCA only
reported one canonical weight vector with respect to SNPs, and
thus, we stacked u for four times. T-MTSCCA yielded four ut’s,
with each being associated to one time point. Finally, the canonical
weights across 10-folds were averaged to make a stable selection.
T-MTSCCA yielded a clear time-consistent and time-dependent
pattern with respect to selected features (SNPs) across multiple time
points owing to the jointly learning and the novel constraint.
TGSCCA and mSCCA could only identify time-consistent imaging
QTs. The reason is that both methods output only one canonical
weight vector based on their modeling strategy, and thus cannot
identify those ones being involved at a specific time point. This
reveals that our method performs cleverly and suitably in longitu-
dinal feature selection studies. For the selected features, we observed
that the SNPs identified by T-MTSCCA have been reported to show
increasing risk for AD or MCI progression in previous studies.
Specifically, there are evidences showing that rs76692773
(TOMM40) and rs112262807 (PVRL2) were AD-risk loci.
rs141622900 (APOC1) is a determinant of the cholesterol efflux
Capacity (CEC) (Low-Kam et al., 2018), whose reduction is a sign
of MCI or AD (Yassine et al., 2016). rs76075198 (CEACAM19) is a
loci associated to Dyslipidemia which shares some pathology with
AD (Carlsson, 2010). It warrants further investigation to confirm
the effects of the remaining loci since they were within in AD-
associated genes such as PVRL2 (rs7343130), and RELB
Table 1. Participant characteristics
HC MCI AD
Num (n) 125 192 91
Gender (M/F) 73/52 122/70 65/26
Handedness (R/L) 112/13 178/14 86/5
Age (mean 6 SD) 74.446 6.58 75.26 6 6.85 74.126 7.07
Education (mean 6 SD) 15.626 2.96 16.27 6 2.83 16.146 2.64
Time point
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Fig. 3. Comparison of the mean canonical correlation coefficients (CCCs)
obtained from 10-fold testing trials on ADNI.
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Fig. 4. Comparison of canonical weights in terms of SNPs averaged from 10-
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(rs141652051) (Nho et al., 2017), BCL3 (rs7249244 and
rs2927462) (Xiao et al., 2017), CEACAM19 (rs141846480) (Jansen
et al., 2019), CLPTM1 (rs12983572) (Hao et al., 2018). TGSCCA
and mSCCA also identified AD-associated loci such as rs57537848
(Nazarian et al., 2019) and rs76692773, as well as loci falling with-
in AD-risk genes such as rs1166329 (PVRL2) and rs7249244
(BCL3) which have not been reported to be associated with AD or
MCI. Given these meaningful results, further investigation, such as a
post-refined analysis, is warranted to confirm the role of these SNPs
during the AD progression. It is interesting that all three method did
not identify rs429358 which is a well-known AD risk locus. This
might stem from the reduced effect of rs429358 in the AD progres-
sion, and, of course, it warrants further investigation to conform
this. In summary, the results regarding SNPs selection show that the
proposed method can not only identify SNPs being effective across
multiple time points, but also identify those being only effective at a
specific time point. This reveals that T-MTSCCA could be suitable
to identify meaningful genetic markers in a longitudinal scenario.
3.3.3 Identification of time-consistent and time-dependent QTs
We want to know the dynamic patterns of imaging QTs longitudin-
ally as well, which shows the interior behavior of diseases progres-
sion. We averaged each vt across 10-folds to assure a stable
selection. These averaged results of every method on each imaging
modality (BL, M6, M12 and M24) were shown in Figure 5. Since
TGSCCA could not yield sparse results due to the lack of individual
sparse-inducing term, we show the top 10 imaging QTs with the
highest absolute weight values. As expected, mSCCA identified ir-
regular non-zero imaging QTs which is time-dependent for each in-
dividual time point due to the lack of temporal constraint. TGSCCA
and T-MTSCCA yielded consistent imaging markers across all time
points, indicating their ability in finding time-consistent markers. T-
MTSCCA also identified imaging QTs being only effective at one
time point, e.g. baseline screening in this study. We then investigated
this by conducting a two-view SCCA between SNP data and imaging
data at each time point separately (results were not shown due to
the space limitation). These four independent tasks showed that the
association pattern at BL is not closely correlated to those of the
three successive time points, i.e. M6, M12 and M24. Therefore,
there is a significant difference with respect to the non-zero imaging
QTs between BL and M6, M12 and M24. This, on the contrary,
demonstrates the value of T-MTSCCA for its time-dependent fea-
ture selection.
T-MTSCCA identified seven imaging markers across all time
points, indicating its ability in discovering time-consistent features.
A literature search shows that all these brain areas are relevant to
MCI or AD. For examples, the right angular gyrus, in which the glu-
cose metabolism shows significant reduction, is associated to aging-
associated cognitive decline (AACD) (Hunt et al., 2007). The right
middle frontal gyrus, the orbitofrontal cortex, the left insula, the left
lingual gyru, and the left occipital were reported as AD-relevant
brain regions in previous studies (Holroyd et al., 2000; Van Hoesen
et al., 2000; Yao et al., 2010). T-MTSCCA also reported several
AD-associated imaging QTs, such as the right fusiform gyrus (Wang
et al., 2015) and the left precuneus, at baseline. It is worth mention-
ing that the left precuneus has been demonstrated to be associated
with early onset AD (Karas et al., 2007). This is promising since T-
MTSCCA could successfully identify the neurodegenerative bio-
marker at its early stage. In addition, T-MTSCCA also captured the
aging-associated areas, such as the left calcarine cortex which shows
predominantly atrophy with age (Bakkour et al., 2013). This is
interesting that, due to the unsupervised modeling strategy, our
method could capture the temporal characters of the brain change
happening to both HCs and ADs, thereby it can also be applied to
brain aging studies. TGSCCA and mSCCA also identified imaging
markers that were associated with MCI or AD, e.g. the left and right
olfactory and the left and right parahippocampal gyri. To summar-
ize, T-MTSCCA identified both time-consistent and time-dependent
imaging QTs, which could help uncover the different changing pat-
terns during different periods in MCI and AD progression, as well as
the change caused by aging. This finally reveals that, using time-
consistent and time-dependent constraints simultaneously, T-
MTSCCA could be very promising in longitudinal brain imaging
genetics.
4 Conclusion
Studying the associations between multiple genetic markers and
brain imaging measurements is an important task in brain science,
with the aim to uncover the genetic basis of the brain structure,
function and disorder. Longitudinal study is widely used in biomed-
ical studies where the brain imaging measures are collected repeat-
edly over long periods of time. These longitudinal data carry rich
information with respect to the disorder progression and brain
aging. Most existing imaging genetics methods only use the baseline
neuroimaging data, and thus ignore useful information embedded in
the longitudinal imaging data across multiple time points. In this art-
icle, we present a novel temporal multi-task SCCA (T-MTSCCA)
method which can identify time-consistent and time-dependent
phenotypic and genotypic markers simultaneously. Being distinct
from existing temporal SCCA, T-MTSCCA treats those temporally
correlated SCCA jointly other than enforcing them to be the same.
This strategy seeks common ground while reserving differences and
can identify both time-consistent and time-dependent markers, and
thus has better modeling ability. An efficient algorithm is proposed
to optimize the problem, which is guaranteed to converge to a local
optimum.
We compared T-MTSCCA with two state-of-the-art counter-
parts, i.e. the mSCCA (multi-view SCCA) (Witten and Tibshirani,
2009) and TGSCCA (temporally constrained group SCCA) (Hao
et al., 2017) using both synthetic data and neuroimaging genetic
data from the ADNI database. On the synthetic data, T-MTSCCA
obtained better CCCs than the benchmarks and identified clearer ca-
nonical weight patterns which were consistent to the ground truths.
On the real neuroimaging genetic data, our method obtained better
or equal CCCs to mSCCA and TGSCCA at multiple time points. It
succeeds in identifying a small set of SNPs and brain imaging QTs
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Fig. 5. Comparison of canonical weights in terms of each imaging QTs aver-
aged from 10-fold cross-validation trials. Each row corresponds to a SCCA
method: (1) mSCCA; (2) TGSCCA and (3) T-MTSCCA. Within each panel, there
are four rows corresponding to four time points of imaging QTs, i.e. BL, M6,
M12 and M24.
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from all markers involved. It is worth noting that our method can
not only find out time-consist features for SNPs and imaging QTs
across multiple time points, but also identified time-dependent
markers at baseline. These identified imaging QTs and SNPs were
highly correlated to AD or MCI, and thus demonstrated that the
proposed temporal multi-task SCCA could be a powerful alternative
method in longitudinal brain imaging genetics. T-MTSCCA also
identified aging-associated areas in elderly subjects. In the future, we
aim to extend T-MTSCCA to the genome-wide brain-wide study,
since the GWAS-oriented longitudinal brain imaging genetics is a
major challenge.
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